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Activation requirements and biologic properties of 
hapten-specific, major histocompatibility cotnplex class 
!-restricted CDS+ T lymphocytes are not fully under-
stood. To address this issue, a novel CD45 +/major histo-
compatibility complex class I+(H-2k)/Ir/CDSO+ 
dendritic cell line, termed S0/1, which is capable of 
stimulating na'ive, allogeneic CDS+ but not CD4 + T cells 
in vitro, was derivatized with trinitrobenzenesulfonic acid 
and co-cultured for 4 d with syngeneic, naive CDS+ 
T cells. Results obtained showed that trinitrophenyl-
derivatized, but not underivatized S0/1 dendritic cells, 
can induce vigorous proliferation of CDS+ T cells . T-cell 
blasts generated in this fashion were able to lyse syngeneic, 
trinitrophenyl-derivatized targets but failed to lyse under-
ivatized or trinitrophenyl-derivatized syngeneic, n'lajor 
histocompatibility complex class r mutant cells or allog-
eneic targets. The ability ofS0/1 dendritic cells to prime 
C o ntact hyp e rsensitivity (C H S) is a T-ceU- m ediated immune response to reactive haptens that have penet-rated the skin. When haptens, not antigenic by them-selves, bind to resident proteins, they serve as target(s) for lymphocyte attack, leading to intense inflammation. 
Numerous investigations have identified dendritic celJs (DC) of the 
skin (epiderm.al Langerhans cells and dermal D C) as criti cal in the 
inducti on of C HS. It .has been demonstrated that (i) mouse skin 
naturally deficient in Langerhans cells (tail skin) or experimentally 
depleted of fun ctional Langerhans cells prior to immuniza tion (by 
ultraviolet irradiation or topi cal steroid trea tment) £:1ils to induce CH S 
(Toews eta/, 19SO; Lynch ct a/, 19S l ); (ii) hapten-de1ivatized Langerha.ns 
cells, but not other hap ten-conjuga ted epidermal cells (keratinocytes, 
dendritic epidermal T cells), iodu ce sensitiza ti on even when inununiz-
ing conditions are chosen that, in the case of other maj or histocompat-
ibili ty complex (MHC) class IT-bearing antigen-presenting cells (APC), 
result in antigen-specifi c inu11une tolerance (Ptak et a!, 19SO; Tam.aki 
et a/, 19S 1; Sullivan et a/, 19S6); (iii ) T cells stimulated in 11it1V by 
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Abbreviatio ns: APC, antigen-presenting ceU(s); C HS, contact hypersensitivity; 
DC, dendriti c ceU(s) ; Eu3+, Europium; MH C, m<Uor histocompatibili ty com-
plex; MoAb, monoclonal antibody; N C M , normal culture medium; sc, subcuta-
neously; TNBS, 2,4,5-ttinitrobenzenesulfo nic acid; T NCB, trini trochloro-
benzene; T N P, trini trophcnyl; ip, in traperitoneal; iv, in travenous; 
naive, syngeneic T cells in 11i11o was tested in a contact 
hypersensitivity model. C3H/HeN mice were injected 
subcutaneously with identical numbers of (i) trinitro-
phenyl-derivatized S0/1 dendritic cells; (ii) tnmtro-
phenyl-derivatized S0/1 dendritic cells fragmented by 
freeze-thawing cycles; (iii) trinitrophenyl-derivatized 
fibrosarcoma L929; and (iv) trinitrophenyl-derivatized 
lymphoma R1.1 cells. Whereas live trinitrophenyl-deriva-
tized S0/1 dendritic cells were able to sensitize for contact 
hypersensitivity, killed hapten-derivatized S0/1 dendritic 
cells or control cells failed to do so. Thus, we conclude 
that S0/1 dendritic cells, when compared with major 
histocompatibility complex class 1+ non-dendritic cells, 
can effectively prime nai've, syngeneic CDS+ T cells for 
hapten-specific responses, probably due to their better 
costimulatory and migratory properties. Key word: contact 
hypersensitivity. J Invest Dermatol 109:580-585, 1997 
hapten-derivatized Lan gerhans ce lls mediate C HS when inj ected into 
syngeneic recipients (Hauser, 1990) ; and (i v) intradermal inj ec ti on of 
hapten-derivatized MHC class 11 + dermal cells initiates the development 
of delayed type hypersensitivity (Tse and Cooper, 1990) . 
The T-cell response to haptens appears to be more complex th an 
01jginall y believed. Several labo ratOLies have provided evidence that 
C D4+ T cells represent th e effector celJs of C HS (H auser, 1990; 
Kapsenberg et a/, 1992; Kondo et a/, 1996). By co ntrast, studi es in 
mice depleted of either CD4 + or CD S+ T cells suggest that CD S+ T 
cells mediate C HS and that the magnitude of the response is regulated 
by CD 4 + T ce lls (Gocinski and Tigelaar, 1990). Simi larly, recent data 
using mice that are geneti cally defi cient in MB C class I and/o r class 
[) 1nolecul es, demonstrate that MHC class !-restricted CD S+ T cells 
mediate C HS to dinitrofluorobenzene (DNFB), and that MJ-:I.C class 
ll-rest1i cted CD 4 + T cells downregulate this inflanunatory response 
(Bour et a/, 1. 995). This fits the recent observation that T cells in the 
draining lymph nodes of hapten- painted mi ce show pola1ized patte rns 
of cytokin e production, with CD S+ T cells that preferentiaJJy produce 
interfe ron-y, and interleukin (IL)-4/ IL-1 0-secreting CD 4 + T cells (Xu 
et a/, 1996) . In accord with the mmine studies, cl ones of T cells 
isolated from lesional skin of patients with allergy to urushiol were 
found to be of the CD S+ phenotype (Kalish and Johnson, 1990), 
implying an effector role fo r CD S+ T cells in humans as well . 
We have previously shown that th e MHC class 1+ / 11-/CD SO+ D C 
line S0/1 induces proliferation of naive, aJJogeneic CD S+ but not 
CD4 + T cells iu vitro. CD S+ T cells thus ac tivated lyse target ce Lls 
expressing th e MHC class !-specificity of the stimula to r cell (Elbe et a/, 
1994). The sensitizing power of 80/1 D C iu vi11o is evidenced by th e 
recent findjn g that allo- class I expression on S0/1 D C is suffic ient to 
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sensitize H - 2-disparate recipi ents for accelera ted rejectio n of skin grafts 
(Lenz et a/, 1996) . Thus, we felt that tlus DC line could be an ideal 
tool to investigate the activation requirem ents ofhapten-specific, MH C 
class !-restri cted CDS+ T lymphocytes. 
MATERIALS AND METHODS 
Animals C3H/ HeN (C3H) (H-2k) and CS7BL/6 (B6) (H-2b) inbred mice 
(6-JO wk old) were obtained from the R.esearch Institute fo r Experimental 
Animal Breeding and Containment of the Vienna University, 1-limberg, Austri a. 
For iu vivo experiments only female mice were used. All animal procedures 
were approved by the Austrian Ministry of Science, Transportation, and Art 
(GZ 66.009/ 160-Pr/ 4/9S). 
Cell lines and monoclonal antibodies (MoAb) The D C li ne 80/1 (MHC 
class 1+ / W/CD45 + /C D3-/CDS4+ /COSO+ /CD S6-) was generated from skin 
of day 15 C3 H. mouse fetuses and maintained in long-tem1 culture in RPM I 
'1640 supplemented with I 0% heat-inactivated fetal bovine senun (FBS) , 2 mM 
L-glutamine, 1 mM sodium pyru va te, 0.:1 mM nonessential amino acids, 25 mM 
HE PES, 50 ~Lg gentamycin per ml , 1 X antibiotic/antimycotic solu tion , and 
50 j.lM 2-ME (all fro m GillCO Li fe Technologies, Grand Island , NY) [normal 
culture medium (NCM)]; the cultures were, in addition, supplemented with 
IL-2 IS U recombinant human IL-2 per ml (Amersham, Buckingamshire, U.K.) 
and murine IL-2 (0 .3% culture supernatant of the IL-2-producing myeloma 
cell line X63AgS-6S3; kindly provided by Dr. F. Mclchers, Basel Institute for 
Immunology, Basel, Switzerland)], and 2 j.lg Concanavalin A (Con A; Pham1acia , 
Upps:lla, Sweden) per ml. The fibrosarcoma cell line 1929 (H-2k; CCL I) and 
the T-cell lymphoma line EL4 (H-2b; TIB 39) were purchased from the 
Ameri can Type C ulture Collection (Rockville, MD). The T-cell lymphoma 
lines R 1.1 (H-2k) and R 1 E (H-2kl (Hyman and Stallings , 1976) were 
generously provided by Dr. F. Karlhofer (D IAID, Dc.:partment of Denmtology, 
University of Vienna Medical School, Vienna , Austria). MoAb 16-l OA 1 (anti-
C OSO) , 3E2 (a nti -CDS4), 15-5-SS (a nti - H-2Dk-al / a2), 53-6.7 (a nti-CDS) , 
and isotype control antibodies were purchased fi·om Pha.rMingen (San Diego, 
A) . Purified hamster lgG was obtained fi·om Cappel (West Grove, PA) . 
Hybridoma '15-3-lS (a nti- H-2KkDk-a l/a2; HB13) and l6-3-1 N (anti-H-
21<\ I-IB2S) were obtained fi·om the American Type C ulture Coll ection. 
Hapten-n1odification of cells CcUs were washed rwice in Hank's balanced 
salt solu tion without Ca2+ and Mg2+ and then incubated (107 cells per ml) 
with 2,4,S-trinitrobenzenesulfonic acid (TNBS; Sigma C hemical Co., St. Louis, 
MO) at a concentration of 5 mM (pH 7.2) for 10 min at 37°C, fo ll owed by 
three washings in a 10-fold excess ofRPM I 1640 contai ning 10% FBS (viability 
> 90% as measured by trypan blue exclusion). 
T-cell proliferation assay 80/ l DC and L929 cells were x-irradiated (1 .5 
Gray per min , Philips RT 30S, Philips, Vienna , Austria) at 40 and 60 Gray, 
respectively, and a portion thereof was derivatized with TNBS. Na'ive, syngeneic 
C DS+ T cells were obta ined according to a protocol described elsewhere (Eibe 
et a/, 1994) (97-99% purity) and cultu red at 105 ce lls per well with stimulator 
cells (104 cells per well) in 96-well round-bottom plates (Costar) .in either 
NCM or NC M supplemented with 50 U recombinant human IL-2 per mi. 
After 3, 4, and S d, cells were pulsed with eHJthymidine (TdR.) (37 kBq per 
well; Amersbam) for S h and incmporation of the radionucleotide was assessed 
by ~-scintilla tio n spec troscopy (Packard lnstmments, Meriden, CT). Data are 
eJ>'Pressed as mean values± SD ofsi.x replicates per group. Inhibition ofT-cell 
pro li feration with MoAb was perfonned by their addition as previously descLibed 
(Eibe et a/, 1994) . 
Cytolytic T lymphocyte assay Purified CDS+ T cells (2 X 106 per well) 
were co-cul tured with trinitrophenyl (TNP)-derivati~ed or, as a control, 
underivatized, syngeneic, incadiated 80/'l DC (2 X 1 0" per well) in 24-we!J 
Rat-bottom culture plates (Costar). After 4 d of culture in N C M or medium 
containing 50 U recombinant human IL-2 per ml , cells were pooled and 
enriched for viable cells using a Lympholyte-M gradient (OD 1.087; Cederlane 
Laboratories, Hornby, O ntaLi o, Canada) . Their cytotOJ-ic potential was measured 
in an Europium (Eu3+) release assay that was performed essentially as described 
(E ibe et a/, 1994). Varying numbers of effector cells were mixed with fixed 
numbers ofEu3+ -labeled, hapten-derivatized or underivatized target cells (R1 .1 , 
R1E, EL4, S0/1 DC, L929, or spleen cells from C3 H and D6 mouse strains 
cultured for 72 h in N CM contain ing 2 j.lg Con A per ml). The percentage of 
specific lys.is was calculated by the formula: 
experimental Eu3+ release - spontaneous Eu3+ release 
% specific lysis = X 100 
max;mum Eu3+ release - spontaneous Eu3+ release 
ln all instances, spontaneous Eu3+ release was between 10 and 20% of the 
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maximum release obtained by 1% Tri ton X-100 lysis. SD of the means of 
triplicates were less than S% and are omitted fi·om the fi gures for clarity. 
Sensitization and elicitation ofCHS C3H mice were anesthetized intraper-
itonea ily (ip) with nibromoethanol (Aldrich Chemical Company, Steinheim, 
Germany; 2.5% in isotonic sahne, 350 ~I per mouse). A posi tive control panel 
of mice was painted on dry shaved abdominal skin with either SO ~I of 2% 
trinitrochlorobenzene (TNCB; T I, Tokyo Kase i, Tok"Yo, Japan) or 2S J.ll of 
0.5% DNFB (S igma- Aldrich, Vienna, Austria) in a 4:1 acetone and olive oil 
ca rri er solution (epicutaneous control panel). Other panels ofnuce were injected 
with selected hapten-derivatized and , for control purposes, unde1ivatized cells 
(titrated cell numbers: '1 04- 107 cells per mouse) in 100 J.ll HBSS with Ca2+ 
and M!?+, either subcutaneously (sc; into the base of the tail), intravenously 
(iv; into the tail vein) or ip . Five days later, these three panels and a na'ivc, 
negative control panel were challenged on the dorsal and ventral surf.1ces of 
their right ears wi th 20 J.ll ofO.S% TNCB. ln some expe1iments, as a specificity 
control, the other car was painted with 0.2% DNFB. Ear thickness was measured 
with an engineer's micrometer (Hahn und Kolb, Stuttgart, Germany) before 
challenge and at certain intervals up to 72 h after challenge. The prechallenge 
value was subtracted fi·om the value assessed at selected time points after 
challenge. Experimental groups consisted of four mice each. 
Histologic analysis of challenged ear tissue Following euthanasia, ea rs 
were removed from mice 24 h after challenge and fLxed in 10% bufre red 
formalin . T he tissue was embedded in paraffin, sectioned, and stained w ith 
hematoxyli n and eosin . 
Statistical analysis O rdinary one-way ANOVA was used to evaluate the 
signi ficance of "'-'Pelimental IICYS IIS control group data. 
RESULTS 
TNP-derivatized 80/1 DC prime naive, syngeneic CDS + T cells 
iu vitro U sing a hapten model, w e attempted to detennine w h ether 
S0/ 1 D C can serve as APC for the stim.ulatio n of naive, syngeneic 
CDS + T cells. For thi s purpose, S0/1 DC were either derivatized 
with TNBS or not and co-cultured for 3-5 days with nai've, syngeneic 
C D S+ T cel.ls. W e fo und that TNP-derivati zed S0/1 DC, but ·not 
undeL-iva ti zed S0/ 1 DC, induce vigorous p roliferative responses in 
CDS+ T cells with peak responses occurring on day 4 (Fig 1). 
Inspec tio n of culture w ells 1-3 d after initiatio n revealed cluster 
form ation betvveen sti mulato r and responder cells, indicating T-cell 
proliferation and lymph okine productio n . In an attempt to generate 
higher numbers of proliferating T cells, we added recom binan t human 
lL-2 to the co-cultures of S0/1 DC and CDS+ T cells. This led co a 
more vigorous T-cell response to both underi va ti zed and hapten-
derivatized S0/ 1 D C, but the proliferatio n induced by TNP-deriva tized 
S0/1 DC remained significantly higher (data no t sh own). To determine 
whether oth er MHC class l + cells, w hen derivati zed with TNBS, are 
also able to stimulate nai've, syngeneic CDS+ T cells iu tlitJV, we tested 
th e MHC class 1+ fibrosarcoma L929 cell line in a similar experimental 
setting as described above. Derivatized L929 cells, which express levels 
of MHC class I molecules compara ble with those of S0/ 1 DC, £1iled 
to induce a significant proliferative response of llai've , syngeneic cos+ 
T cells (Fig 2). This shows that MHC class I expressio n on stimulato r 
cells does not suffice to induce productive T-cell responses and implies 
that the abili ty of S0/ 1. DC to stimulate T-cell proliferation in th e 
absence of MH C class II m olecules is presumably due to the additional 
deliveLy of co-stimulatOLy signals. To test this possibility, we performed 
the co-cultures of T NP-S0/1 DC with CDS+ T cells in the presence 
of antibodies that block the functio n of di ffe re nt co-stimuJatOLy 
.molecules. Table I shows that the anti-CDSO MoAb 16-10Al , but 
not its isocype control, essentially abroga ted the T-cell proliferati ve 
response. The inhibition ind uced by anti-CD54 MoAb was much less 
pronounced. These o bservatio ns point to the cri tical involvem ent 
of the B7-C D 2S/ CTLA-4 receptor-counter-receptor pairs for the 
productive presentation in o ur system. 
The generation of hapten-specific T cells is MHC class !-
dependent In o rder to d ete rmine whether the CDS + T-cell response 
to TNP-derivatized S0/1 DC is regu la ted by MH C class I molecules, 
selected M oA b directed against different MJ-JC class I d etennina.nts 
were added to the cultures. As shown in Table I , the continuous 
presence of the MoAb 15-3-lS that is directed against H -2Kk and 
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Figure 1. TNP-derivatized 80/1 DC induce vigorous proliferative 
responses in nai"ve, syngeneic CDS+ T cells. Irradiated, undcriva tized <• J 
or TNP-derivati zed (0) 80/1 D (1 04 per well) were co-cultured with na!ve, 
syngeneic CDS+ T cells (105 per well) in 96-well round-bottom culture plates. 
O n days 3-5, cells were pu lsed with [31-IJTdR. for an additional 8 h. Data are 
expressed as mean ± SD of six replica tes per group . When cultured alone, T 
cells (nonstimulated or Con A-activa ted), as we ll as irradiated stimulators, did not 
prolife rate. Experiments were repeated fo ur times, yielding comparable resul ts. 
Figure 2. T N P-derivatized 80/l DC, but not L929 cells, induce 
proliferation of syngeneic T cells. Irradiated, underi vati zed, or TNP-
deri vatized 80/1 DC or L929 cells were co-cultured with naive, syngeneic 
CDS+ T cells as desc1ibed in Fig 1. O n day 4, cells were pulsed with ['H]TdR. 
fo r an additional 8 h. Data are expressed as mean ± SO of six repli ca tes per group. 
Table I. Inhibition of TNP-S0/1 DC-induced Cos+ T-Cell 
proliferation by MoAb" 
MoAb added 
none 
h lgG (isot. crrl.) 
COSO (16- IOAl) 
CD54 (3£ 2) 
mlgG2a (isot. ctrl.) 
Kl<D k (15-3-1 S) 
K k (16-3-1N) 
ok ( J 5-5-SS) 
rl gG2a (isot. ctrl .) 
CDS (53-6.7) 
e H)-Td.R up take (cpm) ± SD 
163,273 ± "13,0201! 
172,430 ± 8,443 
1"1 ,099 ::':: 854 
96,300 ± 1"1 ,18 1 
J 49,121 ::':: 15,570 
33,663 ::':: 4,550 
39,433 ± 5,9 19 
177,677 ± 9,015 
174,50 1 ::':: 15,234 
13,007 ± 1,620 . 
111rrad iatcd, T N P-dcri vatizcd 80/ 1 DC and n:fivc, syngeneic CDS+ T cells wen;! co-
cultured fo r 4 d:tys i_n the conti nuous presence of the indi cated MoAb ( 1- 10 J...Lg per ml). 
Cell pro li fc r:ttion was measured by !3H]TdR incorpo ration . 
"VaJucs represent means of nine replic:ttcs per group :t SD. 
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Figure 3. Cytotoxicity of CDS + T cells after stimulation wit11 TNP-
derivatized, syngeneic 80/ 1 DC. Irradiated, TNP-derivatized 80/ 1 DC 
(2 X 105 per well) were co-cultured with na"ive, syngeneic CDS+ T cells 
(2 X 106 per well) in 24-well Aat-bottom culture plates in the presence of 
recombinant human IL-2 (50 U per ntl). After 4 d of culture, a varying number 
of eflcctor cells was mixed with ft:xed numbers of Eu3+ - labeled, underi vatized, 
or TNP-deri va ti zed (A) syngeneic (C3 H) or all ogeneic (B6) Con A-stimulated 
spleen lymphoblasts or (B) syngeneic (MH C class 1+ P-.1.1, MH C class 1- R1 E) 
or all ogeneic (MH C class 1+ EL4) tumor cell lines. After a 4- h incubation, 
supernatan ts were harvested fo r determination of percentage specific lys is. Data 
shown are representa tive f.i·om one out of two (A) or si..x (B) experiments . 
also cross-reacts with H-2D k de termin3nts, greatly diminished th e 
hapten-specific T-cell respo nse . A similar result was o btain ed w hen 
the H -2K k-specific M oAb 16-3-lN w 3s added to the primary c ul tu res. 
In contras t, the additio n of th e H -2Dk M o Ab 1. 5-5-5S did no t show 
an inhibito ry effect. These resul ts dem o nstrate that, in o ur system , H -
2Kk rather than H -2D k mo ieties are in volved in hapten recogniti o n. 
W e also o bserved that the add itio n of the anti-COS M oAb 53- 6 .7 , 
but no t its isoty p e control, almost entire ly prevented T-cell prolife ration. 
In summary, these data sho w that the primi ng o f CO S+ T cells by 
hapten- de ti vatized 8011 D C occurs via the MHC class I-CD S pathway 
in a helpe r cell-independent Gshjo n . 
TNP-derivatized, but not tmderivatize d, 80/1 DC stitnulate 
nai"ve, syngeneic CDS + T cells for cytotoxicity To study th e 
cytolyti c acti vity o f T-cell lympho blasts that had been generated in a 
4-d co-culture of T NP- deri vatized 80/1 D C and syngeneic C o s+ T 
cells, w e perfo rmed an Eu3 + -release assay, using selected TNP-
de ri vati zed o r underi va ti zed syngeneic and allogeneic cells as targets. 
W e o bserved in repeated experiments that TNP-S0 / 1 D C -prim ed 
c o s+ T cells display sign iftcant lysis ofTNP-derivatized- H-2k targets 
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( on A-stimubted spleen lymphoblasts, R1.l , 80/1 DC, L929) but 
not of underi va tized (Con A-stimulated spleen lymphoblasts, Rl.l , 
80/1 DC, L929), TNP-derivatized syngeneic MHC class r- targets 
(R1 E), and H -2b targets (Con A-stimulated spleen Jymphoblasts, EL4) 
(Fig 3A and B and data not shown). Taken together, these data provide 
evidence that 80/1 DC can induce MHC class !-restricted cytotoxic 
T-lymphocyte ac tivity in primed CDS+ T cells in the absence of help 
by CD4 + T cells. 
TNP-derivatized 80/1 DC immunize for CHS in vi11o To 
determi ne whether 80/1 DC are also able to prime na:ive T cells 
i11 1ivo, we used th e CHS model. We fo und that TNP-derivatized 80/ 
1 DC, introduced sc, induce a CHS response th~t was sinular in 
20 
Cl [==-en +I 15 4==-=--== E' "'E 
-1 0 X 
"' 
10 
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c 
"" u :s 
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24 48 72 
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Fig ure 4. TNP-derivatized 80/1 DC prime for CHS iu 11i110 . O n day 0, 
C3H mice were injec ted sc with TNP-derivati zed 80/1 DC (0) o1· painted on 
abdominal skin wi th TNCB (e ). T he nega tive control panel (0) received no 
tr·ca tment. O n day 5 all m.ice were challenged with TN CB on both sides of 
une ear. Ear thi ckness was measured 24, 48, and 72 h later. 
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/ 
-
MHC CLASS W DENDR.ITIC CELLS PRIME FOR CHS 583 
magtutude and kineti cs to that elicited by epicutaneous sensitiza tion 
(Fig 4). In contrast, w hen T NP-deriva tized 8011 DC were administered 
iv o r ip, they failed to sensitize at any cell concentration tested (data 
not shown). 
Histologic exanunacion of ear biopsies fi·om TNCB-sensitized mice 
(Fig SA) and from mice inj ected sc with TNP-80/1 DC (Fig SB) 
showed a pronounced inflammatory reaction that was characterized by 
interstitial oedema and infiltration of inflammatoty cells. TNCB-
challenged ear tissue from unsensi6zed nuce did not exhibi t marked 
oedema or cellular infiltrate (Fig 5 C). 
To test the specificity of the TNP-induced immune response, mi ce 
were sensi tized vvith TNP-derivatized 80/1 DC and then challenged 
with either TNCB or DNFB . As seen in Fig 6, recipients of TNP-
deri vatized, but nor underivatized, 80/1 DC moun ted a signifi cant 
C HS response w hen challenged with T N CB on the right ears. By 
contrast, the sam e expetimental a1umals, w hen challenged with DNFB 
on the left ears, did not develop an ear swelling response to this hapten. 
These data indicate that the C H S response induced by TNP-derivatized 
80/1 DC is restricted to the in.itial hapten-self detemunants seen upon 
ptimaty immLmj za ti on. 
To inves tiga te w hether the strong sensitizing capacity of 80/ 1 D C 
is an intri nsic property of all MHC class I+ cells, we tested rwo other 
cell Ji nes of the sa me haplotype and similar MHC class 1 expression 
levels (L929, Rl.1 ) for their capacity to prime for C HS. 80/ 1 DC, 
L929, and R1.1 ce lls that had been TNP-derivatized were inoculated 
sc (1 06 cells per mouse), and 5 days later all nuce and the negacive 
contro l panel were challenged with TNCB on both sides of their right 
ears. Figure 7 documents the sensitizing power of haptenized 80/1 
DC, as well as the inabili ty of nonprofessional APC (TN1)-derivatized 
L929 and Rl.l_ cells) to ptime fo r C HS. 
Haptens are directly presented b y 80/1 DC To detenn.ine 
w hether sensitizatio n fo r C HS, under the experimental conditions 
chosen in tlus study, rem its from direct hapten-presentation by 80/1 
DC to nai:ve T cells in lymphoid o rgans or, alternatively, from 
indirect hapten-presentation by host APC, we compared the sensitizi11 g 
Figure 5. Histologic features of ear tissue 24 h after challenge . O n 
day 0, mice received the fo llowing treatments: (A) TNCB painting; (B) sc 
injection of TN1>-80/ l DC; and (C) no sensitiznion. All mice were 
chall enged w ith T['ICB on day 5. Ears were removed 24 h after chalk nge, 
fi xed in 10% fo rmalin , sections prepared and stained with hcrnatox:i lin and 
eosin , and photographed. Cross-sections of the corresponding cemral area 
of the ears are shown at the sa me magn ifica tion. Scale bar, 160 ~1111. 
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capa ities of viable and fragmented S0/1 DC. ·w e found that, in 
contrast to recipients of li ve TNP-modified S0/1 DC, anima ls injected 
with ce ll fragments of I 06 TN P-derivatized S0/1 D C did not develop 
a C HS response when ea r-chall enged with TN B (Fig 8). These 
results .lend support to the concept that the sensiti?-ing power of hapten-
modified S0/1 DC res ides in their capacity to approach and directl y 
interact with na:ive T cells. 
DISCUSS ION 
The questio n whether profession al and / or semiprofessional APC ca n 
directly prim e CDS+ T ce lls in the absence of CD4 + T cells has long 
been a matter of debate (Elbe and Sting! , 1995) . In this study, we have 
shown that TNP-derivatized 80/1 D can generate hapten-specifi c, 
MHC class [-restricted cos+ cytotoxic T cells in 11itro in the absence 
of help. We undertook great efforts to exclude an influence of CD4 + 
T ce lls and MH C class II molecules on our i11 11itro sys tem. These 
included a very sttingent puriftca tion procedure of c o s+ lymph node 
T cells and the use of stimulator ce lls b cking no t only constituti ve, 
but also cytokine-inducible (A. Elbe-Bi.irger, manuscript in preparation) 
(/) 
(/) 
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Q) 
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TNCB 
challenge 
DNFB 
chall enge 
Figure 6. Mice injected with TNP-derivatized 80/1 DC respond to 
relevant, but not irrelevant hapten . C3H mice were inj ected sc with 
undcrivatized or TNP-derivatized 80/ '1 DC or painted on abdominal skin with 
either TNCD or DNFB. Two negative control panels did not receive any 
treatment. On day 5, mice "were challenged with TNCB (blnck bars) on one ea r 
and with DNFB (1/Jhire bars) on the other ear. Ear swelling response was 
measured after 24 h. *p < 0.05; **p < 0.0 ·1. 
0 2 4 6 8 10 12 14 
tJ. ear tt)ickness (x10-2 mm) :r SO 
Figure 7. TNP-derivatizcd 80/1 DC, but not oth~r syngeneic MHC 
class 1+ /Ir cells prime for CHS. Panels of C3 H mice were injec ted sc 
either with one of the three TNP-deriva ti zed cel l lines 80/ I, L929·, or R 1.1, 
or with underivatized 80/1 DC. The positive and negative control panels were 
treated as in Fig 4. O n day 5 all mice were challenged with TNCB on 
both sides of one ea r. Changes in ear th ickness were measured 24 h later. 
*p < 0.05; **p < 0.01' 
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MHC class II express ion. Sti ll , we observed abundant cluster formation 
between TNP-detivatized S0/ 1 D C and CDS+ T cell s. This interaction 
is m!'!diated and restricted by MH C class I antigens as evidenced (i) by 
the capacity of an anti -MHC class I (H-2Kk but not H-2Dk) mAb to 
almost cpmpletely abo lish TNP-S0/1 DC-indu ced syngenei c CD S+ 
T-cell pro liferati on, and (ii ) by th e cytotoxic activity of TNP-S0/ '1-
primed COS + lymphoblasts against syngeneic, TNP-derivatized but 
not sy ngeneic, MH C class 1- or all ogeneic, TNP-derivatized target cells. 
W hether processing of TNP is required for hapten presentatio n by 
S0/1 D C remains to be elucidated . Due to their chemical structure, 
aromatic haptens ca n be deli ve red via different presentation path way~. 
p ecause of lipid-solubili ty, they may enter the ce ll , react with cyto-
plasmic proteins, and - after processing by the endogenous route - be 
presented to MH C class !- restricted CDS+ T ce lls. Alternatively, direct 
binding of haptens, without processing, to a peptide in the groove of 
surf.1ce M 1-lC class I molecu les may also contribute to recognition by 
CDS+ T ce ll s. Both routes o f hapten presentation have been demo n-
strated for th e hapten urushi ol (Ka lish et a/, 1994). It has also been 
shown that C 04 + and C DS+ T-cell clones recognize haptenated 
peptides and that the position of th e hapten in the peptide is criti cal 
fo r T-ce11 activatio n (Marti n et a/, 1993; Cavani er a/, 1995; Koh ler 
e/ a/, 1995), thus emphasizing the e:>.ristence of both hapten-specifi c 
class !-restricted cos+ T cells and class !! - restricted C D4 + T ce lls for 
a given hapten. 
W e have demonstrated that TN P-derivatized CD SO+ D C, but 
no t TNP-derivatized CDso- fibr:oblasts and lympho ma ce lls, w hen 
ado1i nistered sc, indu ce CHS. Together with rhe finding that th e 
continu ous presence of the anti-CDSO MoAb inhibits the TNP-S0/ 1 
DC-driven syngeneic c o s+ T-cell proliferation by > 90%, and 
experiments showing that .DSO expressio n on S0/ :1 D C is absolutely 
required for the indu ction of accelerated skin graft rejection (Lenz 
et a/, 1996), these data emphasize the necessity of a second signal for 
pr:odu ctive presentation of hapten in our system . 
O m ill vivo data demonstratin g that hapten ized MHC class II- SO/ 
·1 DC, w hen administered sc, can prime for CHS are in keepin g with 
results by other investiga tors, showing that CD4+ T-cell-depleted or 
MHC class 11 -deficient animals exhibit enhanced ear swelling responses 
** 
L929-TNP dead 
c. ear thickness (x10 .2 mm) ± SD 
Figure 8. Only live TNP-derivatized 80/1 DC prime for CHS. 80/ 'J 
DC or L929 cells (1 06 each) were injected sc into C3 1-! mice as underivatized 
cells, TI'!P-derivatized live cells, or TNP-derivatized dead cells (after 
derivatization, cells were adjusted to appropriate cell numbers and then 
fragmented by three freeze-thaw ing cycles; ·cell viabili ty was assessed by trypon 
blue exclusion) . Positive and nega tive control panels and challenge were 
canied out as in Fig 4. Increase in ear th.i,kness was measured 24 h after 
challenge. **p < 0.01. 
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(Gocinski and Tigelaar, 1990; Bour et a/, 1995) . T he inabi.lity of 
fragmented TNP-derivatized 80/ l DC and haptenized fibrob lasts o r 
lymphoma cells to effi ciently prime for C HS suggests that li ve 8011 
DC, and not host APC, directly present hapten to nai've CDS + T cells. 
AJthough the fma l experimen tal proof is sti.IJ Jacking, we propose that 
sc-i nj ected 80/ l DC ca n m.igrate via the afferent lymphatics to reach 
the drainin g lymph nodes in numbers sufficient for sensitization. T he 
similarities between 80/ 1 DC and .cells of the Langerhans ceil lineage 
(Eibe et a/, 1994), as well as evidence obta in ed in prelirninary migration 
studies (A. Kolesaric, unpubbshed observation) , give support to this 
assumption. 
Interestingly, TNP-derivatizec! 80/ 1 DC fui.l to induce C I-I S w hen 
injected iv or ip . Preliminary data indicate that, whereas their ip 
injection is an immunologic nu U event, the iv administration of 
hapten.ized 80/ 1 DC leads to hyporesponsiveness to subsequently 
painted hapten (A. Kolesaric, unpublished observation). We are 
currentl y investigati ng w hether the differences in th e sensitizing C<lpacity 
of 80/l cells applied via different routes are bnked to their migratory 
properties and / or are due to the delivery of di fl:e rent maturatio nal 
stimuli at different tissue .compa rtments. 
O ur data imp ly tha t at least two components, i.e. , co-stimulation 
and migration, ~re essential fo r th e efficient induction ofCHS. Simi.larly 
to other DC lines (K. Ariizumi ct a!, manuscript in preparation), easily 
accessible 8011 DC co uld be a useful tool for a better understanding of 
bo th cellular and molecular events involved in this process. Considerable 
evidence suggests that, upon appropriate modulation (e.g., cytokine 
treatment; Enk et a/, 1993; 1) or oth er treatment modalities (S imon 
et a/, 1991) , irnmun ogenic DC can be converted to tolerogenic APC. 
It is thus conceivable d1at, by the selec ti ve interference with components 
criti ca l for sensitization, 80/ l DC could be a promising therapeutic 
vaccine for CHS and other T-cell-mediated skin diseases . 
We tha11k Prof P Bqgstrcsscr a11d D.: 1': Kar//r ,!fer .for their ad11ice a11d l!a luable 
discussious, Dr: HI. Pirates jcJr critical readiug of 1/u.: mauuscripl , Dr. P. J\1acll )' (Cen!J7! 
d' lll! ll/llllology, Marseille, Pra l/ce) fc>r providi11g the MoAb , S. 0/t.for teclr11iwl assista 11 cc, 
a11d E. Be>gcr.for ani111al cmc. This work"''" supported by a gra11!jiv111 1he A us!rian 
Scimce Poul!rlatiou (P10 79 7-MED [AEBJ). 
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